Form 4 for INMB Inmune Bio, Inc.
Accepted 2021-10-29 00:00:00 ET · period of report 2021-10-27 · accession 0001213900-21-055422 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-29 | 2021-10-27 | INMB | Tesi Raymond Joseph | Pres, CEO, Dir, 10% | S - Sale | $20.00 | -6,517 | 1.49M | -0.4% | -$130.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-27 | S | D | 6,517 | $20.00 | 1,494,300 | D | — | — |